An evaluation of factors affecting activated coagulation time

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 26, Issue 4, 2012, Pages 563-568

  Bosch, Yvonne P J ^a   Weerwind, Patrick W ^a   Nelemans, Patty J ^b   Maessen, Jos G ^a   Mochtar, Baheramsjah ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

activated coagulation time; antithrombin; decreased heparin responsiveness; heparin sensitivity index

Indexed keywords

ANTITHROMBIN; HEMOGLOBIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANTITHROMBIN DEFICIENCY; ARTICLE; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEPARINIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SURGICAL PATIENT; THROMBOCYTE COUNT;

AGED; ANTITHROMBIN III DEFICIENCY; ASPIRIN; FEMALE; HEMOGLOBINS; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; PLATELET COUNT; WHOLE BLOOD COAGULATION TIME;

EID: 84863432039     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2012.03.011     Document Type: Article

References (41)

1. S.J. Brister, F.A. Ofosu, M.R. Buchanan Thrombin generation during cardiac surgery: Is heparin the ideal anticoagulant? Thromb Haemost 70 1993 259 262 (Pubitemid 23222480)
2. J.H. Levy, F. Montes, F. Szlam The in vitro effects of antithrombin III on the activated coagulation time in patients on heparin therapy Anesth Analg 90 2000 1076 1079 (Pubitemid 30253452)
3. G.J. Despotis, A.L. Summerfield, J.H. Joist Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations J Thorac Cardiovasc Surg 108 1994 1076 1082 (Pubitemid 24379861)
4. P.G. Hattersley Activated coagulation time of whole blood JAMA 196 1966 436 440
5. S.D. Niles, R.G. Sutton, J. Ploessl Correlation of ACT as measured with three commercially available devices with circulating heparin level during cardiac surgery J Extra Corpor Technol 27 1995 197 200 (Pubitemid 26003092)
6. M.S. Avidan, J.H. Levy, H. van Aken Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass J Thorac Cardiovasc Surg 130 2005 107 113 (Pubitemid 40941676)
7. M. Ranucci, G. Isgrò, A. Cazzaniga Predictors for heparin resistance in patients undergoing coronary artery bypass grafting Perfusion 14 1999 437 442 (Pubitemid 29537489)
8. J.H. Levy Heparin resistance and antithrombin: Should it still be called heparin resistance? J Cardiothorac Vasc Anesth 18 2004 129 130 (Pubitemid 38506854)
9. S. Bar-Yosef, H.B. Cozart, B. Phillips-Bute Preoperative low molecular weight heparin reduces heparin responsiveness during cardiac surgery Can J Anaesth 54 2007 107 113 (Pubitemid 46505507)
10. G.J. Despotis, V. Levine, J.H. Joist Antithrombin III during cardiac surgery: Effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation Anesth Analg 85 1997 498 506 (Pubitemid 27381298)
11. J.A. Huntington Molecular recognition mechanisms of thrombin J Thromb Haemost 3 2005 1861 1872 (Pubitemid 41716573)
12. D.A. Lane, H. Philippou, J.A. Huntington Directing thrombin Blood 106 2005 2605 2612 (Pubitemid 41510730)
13. K. Hashimoto, M. Yamagishi, T. Sasaki Heparin and antithrombin III levels during cardiopulmonary bypass: Correlation with subclinical plasma coagulation Ann Thorac Surg 58 1994 799 804 (Pubitemid 24319632)
14. M. Ranucci, A. Ditta, A. Boncilli Determinants of antithrombin consumption in cardiac operations requiring cardiopulmonary bypass Perfusion 19 2004 47 52 (Pubitemid 38386649)
15. R.A. Esposito, A.T. Culliford, S.B. Colvin The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass J Thorac Cardiovasc Surg 85 1983 174 185 (Pubitemid 13099670)
16. L. Shore-Lesserson, H.E. Manspeizer, M. Bolastig Anticoagulation for cardiac surgery in patients receiving preoperative heparin: Use of the high-dose thrombin time Anesth Analg 90 2000 813 818 (Pubitemid 30190783)
17. W. Dietrich, S. Braun, M. Spannagl Low preoperative antithrombin activity causes reduced response to heparin in adult but not in infant cardiac-surgical patients Anesth Analg 92 2001 66 71 (Pubitemid 32039179)
18. S. Garvin, D. Fitzgerald, J.D. Muehlschlegel Heparin dose response is independent of preoperative antithrombin activity in patients undergoing coronary artery bypass graft surgery using low heparin concentrations Anesth Analg 111 2010 856 861
19. J.H. Lemmer Jr, G.J. Despotis Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery J Thorac Cardiovasc Surg 123 2002 213 217 (Pubitemid 34127106)
20. S.C. Nicholson, D.M. Keeling, M.E. Sinclair Heparin pretreatment does not alter heparin requirements during cardiopulmonary bypass Br J Anaesth 87 2001 844 847 (Pubitemid 33130273)
21. S. Butenas, C. van't Veer, K.G. Mann "Normal" thrombin generation Blood 94 1999 2169 2178
22. H.C. Hemker, R. Al Dieri, S. Béguin Thrombin generation assays: Accruing clinical relevance Curr Opin Hematol 11 2004 170 175 (Pubitemid 38952005)
23. A. Koster, G.J. Despotis, M. Gruendel The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: A pilot investigation Anesth Analg 95 2002 26 30 (Pubitemid 34705547)
24. S. Garvin, D.C. Fitzgerald, G. Despotis Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements Anesth Analg 111 2010 849 855
25. P.M. Sandset, B. Bendz, J.B. Hansen Physiological function of tissue factor pathway inhibitor and interaction with heparins Haemostasis 30 suppl 2 2000 48 56 (Pubitemid 32234139)
26. E. Brodin, H. Appelbom, B. Osterud Regulation of thrombin generation by TFPI in plasma without and with heparin Transl Res 153 2009 124 131
27. G.J. Despotis, G. Gravlee, K. Filos Anticoagulation monitoring during cardiac surgery: A review of current and emerging techniques Anesthesiology 91 1999 1122 1151 (Pubitemid 29466546)
28. J. Hirsh, R. Raschke Heparin and low-molecular-weight heparin: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 suppl 2004 188S 203S (Pubitemid 39297954)
29. J.I. Weitz Low-molecular-weight heparins N Engl J Med 337 1997 688 698 (Pubitemid 27375477)
30. M.D. Linden, M. Schneider, S. Baker Decreased concentration of antithrombin after preoperative therapeutic heparin does not cause heparin resistance during cardiopulmonary bypass J Cardiothorac Vasc Anesth 18 2004 131 135 (Pubitemid 38506855)
31. S. Colli, J.P. Werba, E. Tremoli Statins in atherothrombosis Semin Vasc Med 4 2004 407 415 (Pubitemid 40577830)
32. T. Chan, N.C. Hwang, C.H. Lim A statistical analysis of factors predisposing patients to heparin resistance Perfusion 21 2006 99 103
33. J.M. Gayoso 5-Year incidence of thrombocytosis and the effect on heparin dose response and heparin requirements J Extra Corpor Technol 31 1999 184 190 (Pubitemid 30176833)
34. D.A. Lane, J. Denton, A.M. Flynn Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4 Biochem J 218 1984 725 732 (Pubitemid 14165173)
35. D.A. Lane, G. Pejler, A.M. Flynn Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4 J Biol Chem 261 1986 3980 3986 (Pubitemid 17198823)
36. M.K. Horne III, E.S. Chao Heparin binding to resting and activated platelets Blood 74 1989 238 243 (Pubitemid 19187435)
37. C.L. Conley, R.C. Hartmann, J.S. Lalley The relationship of heparin activity to platelet concentration Proc Soc Exp Biol Med 69 1948 284 287
38. W.W. Roeloffzen, H.C. Kluin-Nelemans, L. Bosman Effects of red blood cells on hemostasis Transfusion 50 2010 1536 1544
39. G.J. Despotis, A.L. Alsoufiev, E. Spitznagel Response of kaolin ACT to heparin: Evaluation with an automated assay and higher heparin doses Ann Thorac Surg 61 1996 795 799 (Pubitemid 26084536)
40. G.A. Shapiro, S.W. Huntzinger, J.E. Wilson III Variation among commercial activated partial thromboplastin time reagents in response to heparin Am J Clin Pathol 67 1977 477 480 (Pubitemid 8107849)
41. H.C. Hemker, S. Béguin Standard and method independent units for heparin anticoagulant activities Thromb Haemost 70 1993 724 728 (Pubitemid 23339442)